Juniper Pharmaceuticals, Inc., formerly Columbia Laboratories, Inc., is a pharmaceutical company that engages in the development of therapeutics that addresses unmet medical needs in women&#x27;s health. Its pipeline development is funded by cash flows from its CRINONE franchise and services business. It is currently developing COL-1077, a 10% lidocaine bioadhesive gel intended as an acute use anesthetic for minimally invasive gynecological procedures. The company was founded in December 1986 and is headquartered in Boston, MA.
